Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1360, 2011-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Varenicline and CV events: postmarketing experience in NZ
Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. :
Access to resources
Recommend
Serious adverse events reported with trastuzumab
Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. :
ADHD meds not found to increase risk of serious CV events
Reactions Weekly, Vol. 1, Iss. 1377, 2011-01 ,pp. :
Smoking cessation aid may increase risk of adverse CV events
Reactions Weekly, Vol. 1, Iss. 1357, 2011-01 ,pp. :
Off-label Vistide use associated with serious adverse events
Reactions Weekly, Vol. 1, Iss. 1338, 2011-01 ,pp. :